One of the biotech industry’s most esteemed venture capitalists anticipates that, after two years of drought, a wave of drug ...
Tucked inside a 3,000-page national defense bill signed into law last month is a set of new regulations that could upend the way local biotech companies do business. The Biosecure Act, as it is known, ...
Is the biotech industry truly out of its slump? This week on "The Readout LOUD," a biotech year in review and a look ahead to next year's trends.
TipRanks on MSN
Kelun-Biotech’s ADC-PD-1 combo wins breakthrough therapy status in first-line lung cancer
An announcement from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( ($HK:6990) ) is now available. Sichuan Kelun-Biotech announced ...
7don MSN
Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to invest in. On December 8, Sana ...
Boston CEOs point to a rise in funding rounds and M&A deals in late 2025 as evidence that biotech companies are learning to ...
China's biotech revival is pushing up prices of laboratory monkeys used in drug testing, as renewed R&D activity collides ...
The Biotech industry has underperformed due to the Trump administration, RFK Jr.'s skepticism, and funding uncertainty, with major ETFs down 19-25% over six months. Some biotech companies with ...
Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback